ArticleFrontiers in medicine2025
Global, regional, and national burden of orofacial clefts, 1990-2021: an analysis of data from the global burden of disease study 2021.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Application of Artificial Intelligence Models in Oral and Maxillofacial Prosthesis Restoration: A Systematic Review.International dental journal · 2025Pooled it
- Review
- Epidemiological and Clinical Profile of Cleft Lip and/or Palate in Mbujimayi: A Cross-Sectional Study.Health science reports · 2026Article
- Preconception and Early Pregnancy Exposure to Ambient Air Pollution and Risk of Cleft Lip and/or Palate: A Case-Control Study Using Single-Pollutant, Multi-Pollutant, and Mixture-Based Analyses.Birth defects research · 2026Article
- Characterization of Inflammatory Biomarkers in Palatal Tissue of Patients with Bilateral Cleft Lip and Palate.Life (Basel, Switzerland) · 2026Article
- Global, regional, and national incidence, mortality, DALY, and prevalence rates of orofacial clefts in children and adolescents from 1990 to 2021, with predictions to 2050.Archives of medical science : AMS · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Orofacial clefts (OFCs) are congenital craniofacial malformation caused by embryonic developmental abnormalities, characterized by incomplete fusion of the upper lip and/or palate, leading to feeding difficulties, speech impairments, and other functional challenges. OFCs represent the most prevalent congenital malformations of oral and maxillofacial region. We aim to characterize disease burden of OFCs across regions and countries, analyze temporal trends from 1990 to 2021, examine relationship with Socio-demographic Index (SDI), explore gender disparities and predict future epidemiological patterns. Methods: Utilizing GBD 2021 database for 204 countries/regions, we analyzed age-standardized metrics including disability-adjusted life years (DALYs), prevalence, mortality, incidence, using tools like DisMod-MR 2.1 for Bayesian meta-regression. SDI, calculated from educational attainment, per capita income, and fertility rates (range 0-1), stratified nations into quintiles. Statistical analyses included SDI-burden correlations and future projections using Bayesian age-period-cohort (BAPC) modeling, implemented through R software. Results: In 2021, there are a total of 4124006.8 cases of OFCs worldwide, with an age-standardized prevalence rate (ASPR) of 53.4 per 100,000 (95% UI: 43-64). The age-standardized incidence rate (ASIR) was 3.0 per 100,000 (95% UI: 2.2-3.9), while age-standardized deaths rate (ASDR) of 0 per 100,000 (95% UI: 0-0.1). Additionally, age-standardized DALYs rate was 5.8 per 100,000 (95% UI: 3.5-9.8). Regionally, low- to middle-SDI regions demonstrated the highest ASPR and ASIR, whereas low-SDI areas showed the most severe ASDR and DALYs rate. In contrast, high-SDI regions consistently exhibited the lowest burden across all metrics. At the subregional level, South Asia recorded the greatest ASPR, while Central Asia had the peak ASIR. Oceania displayed the highest ASDR and DALYs rate. Country-specific analysis identified Palestine with the maximum ASPR, Kazakhstan with the highest ASIR, Papua New Guinea with the greatest ASDR, and Afghanistan with the most elevated DALYs rate. Conclusion: The global OFCs burden demonstrated consistent decline from 1990-2021, with persistent male predominance. Regional disparities correlate strongly with SDI, particularly affecting Central Asia, South Asia, and Africa populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.